EP2585104
Aðferðir og samsetningar til að koma arýlsúlfatasa A inn í miðtaugakerfið
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.6.2011EP published:
21.8.2019EP application number:
11799037.4
EP translation filed:
7.10.2019Grant published:
15.11.2019EPO information:
European Patent Register
Max expiry date:
24.6.2031Expiry date:
24.6.2026Next due date:
30.6.2026
Title:
METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A
Timeline
Today
25.6.2011EP application
21.8.2019EP Publication
7.10.2019Translation submitted
15.11.2019Registration published
24.6.2026Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka 540-8645, JP
Inventor
Name:
SALAMAT-MILLER, NazilaAddress:
ArlingtonMA, US
Name:
TAYLOR, KatherineAddress:
ArlingtonMA, US
Name:
CAMPOLIETO, PaulAddress:
CharlottesvilleVA, US
Name:
SHAHROKH, ZahraAddress:
WestonMA, US
Name:
PAN, JingAddress:
BoxboroughMA, US
Name:
CHARNAS, LawrenceAddress:
NatickMA, US
Name:
WRIGHT, Teresa LeahAddress:
LexingtonMA, US
Name:
CALIAS, PericlesAddress:
MelroseMA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161435710 PDate:
24.1.2011Country:
US
Number:
201161495268 PDate:
9.6.2011Country:
US
Number:
201161476210 PDate:
15.4.2011Country:
US
Number:
358857 PDate:
25.6.2010Country:
US
Number:
201161442115 PDate:
11.2.2011Country:
US
Number:
387862 PDate:
29.9.2010Country:
US
Number:
360786 PDate:
1.7.2010Country:
US
Classification
Categories:
A61K 38/47, A61P 25/00, A61P 25/28, A61K 9/19, A61K 38/46
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 19.5.2020
Expires: 24.6.2021
Payer: Patice ehf.
Number: 11
Paid: 19.5.2021
Expires: 24.6.2022
Payer: Patice ehf.
Number: 12
Paid: 18.5.2022
Expires: 24.6.2023
Payer: Patice ehf.
Number: 13
Paid: 24.5.2023
Expires: 24.6.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 23.5.2024
Expires: 24.6.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 16.6.2025
Expires: 24.6.2026
Payer: Árnason Faktor ehf.